BE809832A - Compositions pharmaceutiques pour le traitement de maladies de la peau - Google Patents

Compositions pharmaceutiques pour le traitement de maladies de la peau

Info

Publication number
BE809832A
BE809832A BE139887A BE139887A BE809832A BE 809832 A BE809832 A BE 809832A BE 139887 A BE139887 A BE 139887A BE 139887 A BE139887 A BE 139887A BE 809832 A BE809832 A BE 809832A
Authority
BE
Belgium
Prior art keywords
treatment
pharmaceutical compositions
skin diseases
diseases
skin
Prior art date
Application number
BE139887A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE809832A publication Critical patent/BE809832A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE139887A 1973-01-16 1974-01-16 Compositions pharmaceutiques pour le traitement de maladies de la peau BE809832A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32401273A 1973-01-16 1973-01-16
US42506573A 1973-12-17 1973-12-17

Publications (1)

Publication Number Publication Date
BE809832A true BE809832A (fr) 1974-07-16

Family

ID=26984233

Family Applications (1)

Application Number Title Priority Date Filing Date
BE139887A BE809832A (fr) 1973-01-16 1974-01-16 Compositions pharmaceutiques pour le traitement de maladies de la peau

Country Status (3)

Country Link
BE (1) BE809832A (fr)
DE (1) DE2401446A1 (fr)
FR (1) FR2213776A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE888533A (fr) * 1980-04-25 1981-10-23 Hoffmann La Roche Compositions pharmaceutiques et procedes pour le traitement de l'inflammation de tissus dermiques,
US4444780A (en) * 1982-08-30 1984-04-24 Ortho Pharmaceutical Corporation Method for treating atopic dermatitis
WO1991007177A1 (fr) * 1989-11-13 1991-05-30 Pfizer Inc. Derives de pyrimidone et analogues pour le traitement de l'asthme et de certaines maladies de la peau
US5461056A (en) * 1992-05-08 1995-10-24 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
CA2689507C (fr) 2007-06-06 2016-07-26 The Hospital For Sick Children Production d'elastine induite par l'aldosterone
US8618084B2 (en) 2008-06-06 2013-12-31 Human Matrix Sciences, Llc Aldosterone induced vascular elastin production

Also Published As

Publication number Publication date
DE2401446A1 (de) 1974-07-25
FR2213776A1 (en) 1974-08-09

Similar Documents

Publication Publication Date Title
FR2316954A1 (fr) Preparation dentaire pour le traitement de la parodontose
BE778149A (fr) Nouveaux produits pour le traitement et l'hygiene de la peau
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
BE793792A (fr) Compositions pour le traitement de la peau
CH428100A (fr) Composition pour le traitement et les soins de la peau
FR2291740A1 (fr) Preparation pour le traitement des cheveux et de la peau
BE809832A (fr) Compositions pharmaceutiques pour le traitement de maladies de la peau
BE809831A (fr) Compositions pharmaceutiques pour traiter des maladies de la peau
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
BE821888A (fr) Traitement de dispersions de gouttelettes
BE815825A (fr) Composition pour le traitement de la peau
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE814735A (fr) Nouvelle composition pharmaceutique pour le traitement des maladies coronariennes
BE809834A (fr) Compositons de traitement pour les maladies de la peau
BE809833A (fr) Compositions pharmaceutiques pour le traitement des maladies proliferantes de la peau
BE771357A (fr) Composition pour le traitement bactericide de zones isolees de la peau de l'homme et pour le traitement d'affections cutanees.
FR2311553A1 (fr) Medicament pour le traitement de la schizophrenie
BE854412A (fr) Compositions pharmaceutiques pour un traitement gynecologique
BE820222A (fr) Composition therapeutique pour le traitement du diabete par voie orale
BE809835A (fr) Compositions pour le traitement des maladies de la peau
FR2296415A1 (fr) Preparations pharmaceutiques pour le traitement des troubles de la circulation
FR2310770A1 (fr) Medicament pour le traitement de l'alopecia areata
BE829024A (fr) Compositions pharmaceutiques pour le traitement de l'hydropisie
AT322970B (de) Walzwerk zur behandlung von materialeahnen
BE817252A (fr) Composition pharmaceutique pour le traitement des maladies hepatiques